Published Date: 04/15/2022
Expiration Date: 09/23/2024
The prevalence of substance use during pregnancy is increasing across the United States, and has been linked to an increased risk of serious medical complications, such as poor fetal growth, preterm birth and stillbirth. To decrease risk to both the pregnant person and fetus, medical providers can implement a harm reduction approach when providing clinical care. This course will review harm reduction as it relates to pregnant people and outline ways medical providers can apply a harm reduction approach to their interactions with pregnant patients.
Effective June 27, 2023 the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced a one-time requirement of 8 hours of training on the treatment and management of patients with opioid or other substance use disorders for practitioners who are applying for or renewing their DEA license. This 1-hour ACCME-accredited course meets the DEA/SAMHSA requirement.
Dana Kurzer-Yashin has been in Harm Reduction for over half a decade, and is currently based in Philadelphia, Pennsylvania working as a Communications Manager for a health department. She previously worked at the Lower East Side Harm Reduction Center and the National Harm Reduction Coalition, and co-edited Pregnancy and Substance Use a Harm Reduction Toolkit a resource designed for parents, families, birth workers, and harm reductionists.